Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene red Filtered green network_comparison
Results: HTML CSV LaTeX Showing element 2208 to 2257 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein phosphatase inhibitor 2 (ipp-2). [source:swissprot;acc:p41236]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
313\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
21644.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
18098.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1959\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein regulator of cytokinesis 1; protein regulating cytokinesis 1. [source:refseq;acc:nm\_003981]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1887\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5438.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06335\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein sck (fragment). [source:swissprot;acc:p98077]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1827\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein tara (trio-associated repeat on actin) (hrihfb2122). [source:swissprot;acc:q9h2d6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2576\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5608.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5712.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01857\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein translation factor sui1 homolog (sui1iso1). [source:swissprot;acc:p41567]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2023\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3560.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3364.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05807\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein translation factor sui1 homolog gc20. [source:swissprot;acc:o60739]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1988\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3559.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3360.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05925\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec23a (sec23-related protein a). [source:swissprot;acc:q15436]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3135\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec23b (sec23-related protein b). [source:swissprot;acc:q15437]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3127\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec24a (sec24-related protein a) (fragment). [source:swissprot;acc:o95486]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3056\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec24b (sec24-related protein b). [source:swissprot;acc:o95487]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2956\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec24c (sec24-related protein c). [source:swissprot;acc:p53992]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2910\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec24d (sec24-related protein d). [source:swissprot;acc:o94855]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2903\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec61 alpha subunit isoform 1 (sec61 alpha- 1). [source:swissprot;acc:p38378]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2079\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3614.91\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3423.89\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05579\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec61 alpha subunit isoform 2 (sec61 alpha- 2). [source:swissprot;acc:q9y2r3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2078\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein transport protein sec61 gamma subunit. [source:swissprot;acc:p38384]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2265\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3612.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3453.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04606\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein x 0001. [source:refseq;acc:nm\_016302]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1582\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6376.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6833.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07175\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein x 0004. [source:refseq;acc:nm\_016301]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
16\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein-tyrosine phosphatase beta precursor (ec 3.1.3.48) (r-ptp- beta). [source:swissprot;acc:p23467]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
538\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10603.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12069.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13825\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 1 (ec 3.1.3.48) (protein-tyrosine phosphatase 1b) (ptp-1b). [source:swissprot;acc:p18031]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1247\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6278.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6807.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08421\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 11 (ec 3.1.3.48) (protein-tyrosine phosphatase 2c) (ptp-2c) (ptp-1d) (sh-ptp3) (sh- ptp2) (shp-2). [source:swissprot;acc:q06124]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2789\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protein-tyrosine phosphatase, non-receptor type 2 (ec 3.1.3.48) (t- cell protein-tyrosine phosphatase) (tcptp). [source:swissprot;acc:p17706]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1248\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6275.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6803.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08415\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene c-crk (p38) (adapter molecule crk). [source:swissprot;acc:p46108]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
248\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene protein c-fos (cellular oncogene fos) (g0/g1 switch regulatory protein 7). [source:swissprot;acc:p01100]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
83\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4932.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7033.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42597\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase abl1 (ec 2.7.1.112) (p150) (c-abl). [source:swissprot;acc:p00519]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
253\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7859.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fer (ec 2.7.1.112) (p94-fer) (c-fer). [source:swissprot;acc:p16591]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1649\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6079.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6503.12\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06973\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fes/fps (ec 2.7.1.112) (c-fes). [source:swissprot;acc:p07332]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1645\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fgr (ec 2.7.1.112) (p55-fgr) (c-fgr). [source:swissprot;acc:p09769]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
255\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6417.18\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7859.6\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.22477\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase fyn (ec 2.7.1.112) (p59-fyn) (syn) (slk). [source:swissprot;acc:p06241]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
254\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
250\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protocadherin 15 precursor. [source:swissprot;acc:q96qu1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1181\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4392.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4776.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08732\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protocadherin 16 precursor (cadherin 19) (cadherin fibroblast 1). [source:swissprot;acc:q96jq0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2838\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protocadherin fat 2 precursor (hfat2) (multiple epidermal growth factor-like domains 1). [source:swissprot;acc:q9nyq8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1722\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5458.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5830.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protoheme ix farnesyltransferase, mitochondrial precursor (ec 2.5.1.-) (heme o synthase). [source:swissprot;acc:q12887]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
933\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5638.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6194.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09853\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
protoporphyrinogen oxidase (ec 1.3.3.4) (ppo). [source:swissprot;acc:p50336]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2934\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
prp18 pre-mrna processing factor 18 homolog. [source:refseq;acc:nm\_003675]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2707\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8979.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9012.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00364\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ptb domain adaptor protein ced-6; engulfment adapter protein. [source:refseq;acc:nm\_016315]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
364\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5189\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6088.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17334\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ptd016 protein. [source:refseq;acc:nm\_016125]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3093\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
purine nucleoside phosphorylase (ec 2.4.2.1) (inosine phosphorylase) (pnp). [source:swissprot;acc:p00491]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1444\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5450.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5869.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07672\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
puromycin-sensitive aminopeptidase (ec 3.4.11.-) (psa). [source:swissprot;acc:p55786]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
828\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5745.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10602\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putatative 28 kda protein. [source:refseq;acc:nm\_020143]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2747\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4708.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4702.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0013\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative acyl-coa thioester hydrolase cgi-16 (ec 3.1.2.-). [source:swissprot;acc:q9y305]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1060\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5719.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6248.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0926\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative adenosylhomocysteinase 2 (ec 3.3.1.1) (s-adenosyl-l- homocysteine hydrolase) (adohcyase). [source:swissprot;acc:o43865]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
626\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6228.39\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7013.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.126\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
putative adenosylhomocysteinase 3 (ec 3.3.1.1) (s-adenosyl-l- homocysteine hydrolase) (adohcyase). [source:swissprot;acc:q96hn2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
628\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative ankyrin-repeat containing protein. [source:refseq;acc:nm\_025185]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1720\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5458.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5830.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative breast adenocarcinoma marker (32kd). [source:refseq;acc:nm\_014453]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
147\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11068\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8508.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.30082\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative dimethylaniline monooxygenase [n-oxide forming] 6 (ec 1.14.13.8) (flavin-containing monooxygenase 6) (fmo 6) (dimethylaniline oxidase 6). [source:swissprot;acc:o60774]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
952\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5364.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5885.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09716\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative eukaryotic translation initiation factor 1a (eif-1a) (eif- 4c). [source:swissprot;acc:o75642]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2439\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3754.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3629.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03441\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative eukaryotic translation initiation factor 3 subunit (eif-3) (fragment). [source:swissprot;acc:o75153]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1193\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5464.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5940.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08697\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
291\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
44490.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
36927.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20481\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
putative gtp-binding protein ptd004 (pro2455). [source:swissprot;acc:q9ntk5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2089\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5775.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6094.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05535\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/